Predicting total, abdominal, visceral and hepatic adiposity with circulating biomarkers in Caucasian and Japanese American women

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Lim, Unhee ^a   Turner, Stephen D ^b   Franke, Adrian A ^a   Cooney, Robert V ^c   Wilkens, Lynne R ^a   Ernst, Thomas ^d   Albright, Cheryl L ^a,e   Novotny, Rachel ^a   Chang, Linda ^d   Kolonel, Laurence N ^a   Murphy, Suzanne P ^a   Le Marchand, Loïc ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d UNIVERSITY OF HAWAII   (United States)

^e UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIFEDIOL; ESTRADIOL; GASTRONEUROPEPTIDE; INSULIN; LEPTIN; LEPTIN RECEPTOR; LIPID; LIVER ENZYME; LYCOPENE; NEUROPEPTIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; SOLUBLE LEPTIN RECEPTOR; SOMATOMEDIN BINDING PROTEIN 1; UBIDECARENONE; UNCLASSIFIED DRUG; URIC ACID;

ABDOMINAL OBESITY; ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; ASIAN AMERICAN; BLOOD ANALYSIS; BLOOD SAMPLING; BODY FAT DISTRIBUTION; BODY MASS; CAUCASIAN; DUAL ENERGY X RAY ABSORPTIOMETRY; ETHNIC GROUP; FEMALE; HEPATIC ADIPOSITY; HUMAN; HUMAN EXPERIMENT; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIVER; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; POSTMENOPAUSE; PREDICTION; VISCERAL ADIPOSITY; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ABDOMINAL FAT; ABSORPTIOMETRY, PHOTON; ADIPOSITY; AGED; ANTHROPOMETRY; ASIAN AMERICANS; BIOLOGICAL MARKERS; BODY MASS INDEX; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HAWAII; HUMANS; INTRA-ABDOMINAL FAT; JAPAN; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBESITY; PREDICTIVE VALUE OF TESTS;

EID: 84865063374     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043502     Document Type: Article

References (58)

1. Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L, ((2000)) Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care 23:: 465--471.
2. Oh TH, Byeon JS, Myung SJ, Yang SK, Choi KS, et al. ((2008)) Visceral obesity as a risk factor for colorectal neoplasm. J Gastroenterol Hepatol 23:: 411--417.
3. Sorensen HT, Mellemkjaer L, Jepsen P, Thulstrup AM, Baron J, et al. ((2003)) Risk of cancer in patients hospitalized with fatty liver: a Danish cohort study. JClinGastroenterol 36:: 356--359.
4. Balkau B, Lange C, Vol S, Fumeron F, Bonnet F, ((2010)) Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. BMC Gastroenterol 10:: 56.
5. Lemieux S, Prud'homme D, Bouchard C, Tremblay A, Despres JP, ((1996)) A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue. Am J Clin Nutr 64:: 685--693.
6. Camhi SM, Bray GA, Bouchard C, Greenway FL, Johnson WD, et al. ((2011)) The relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: sex and race differences. Obesity (Silver Spring) 19:: 402--408.
7. Ludescher B, Machann J, Eschweiler GW, Vanhofen S, Maenz C, et al. ((2009)) Correlation of fat distribution in whole body MRI with generally used anthropometric data. Invest Radiol 44:: 712--719.
8. van Dijk SJ, Feskens EJ, Heidema AG, Bos MB, van de Rest O, et al. ((2010)) Plasma protein profiling reveals protein clusters related to BMI and insulin levels in middle-aged overweight subjects. PLoS One 5:: e14422.
9. Cohen J, Cohen P, West SG, Aiken LS (2003) Applied multiple regression/correlation analysis for the behavioral sciences. Mahwah, NJ.: Lawrence Erlbaum Associates.
10. Lim U, Ernst T, Buchthal SD, Latch M, Albright CL, et al. (2011) Asian women have greater abdominal and visceral adiposity than Caucasian women with similar body mass index. Nutrition and Diabetes (Epub on Nutrition & Diabetes website. Available: http://www.nature.com/nutd/journal/v1/n5/index_by_arttype.html) Accessed 2012 July 5.
11. Lim U, Ernst T, Wilkens LR, Albright CL, Lun-Jones A, et al. (2012) Susceptibility variants for waist size in relation to abdominal, visceral and hepatic adiposity in postmenopausal women. J Academy Nutr Dietetics in press.
12. Kolonel LN, Henderson BE, Hankin JH, Nomura AM, Wilkens LR, et al. ((2000)) A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. AmJEpidemiol 151:: 346--357.
13. Bosy-Westphal A, Booke CA, Blocker T, Kossel E, Goele K, et al. ((2010)) Measurement site for waist circumference affects its accuracy as an index of visceral and abdominal subcutaneous fat in a Caucasian population. J Nutr 140:: 954--961.
14. Guiu B, Loffroy R, Petit JM, Aho S, Ben Salem D, et al. ((2009)) Mapping of liver fat with triple-echo gradient echo imaging: validation against 3.0-T proton MR spectroscopy. Eur Radiol 19:: 1786--1793.
15. Breiman L, ((2001)) Random Forests. Machine Learning 45:: 5--32.
16. Svetnik V, Liaw A, Tong C, Culberson JC, Sheridan RP, et al. ((2003)) Random forest: a classification and regression tool for compound classification and QSAR modeling. J Chem Inf Comput Sci 43:: 1947--1958.
17. Hastie T, Tibshirani R, Friedman J (2009) The elements of statistical learning: data mining, inference and prediction. New York: Springer.
18. Rodenburg W, Heidema AG, Boer JM, Bovee-Oudenhoven IM, Feskens EJ, et al. ((2008)) A framework to identify physiological responses in microarray-based gene expression studies: selection and interpretation of biologically relevant genes. Physiol Genomics 33:: 78--90.
19. Kim BK, Lee JW, Park PJ, Shin YS, Lee WY, et al. ((2009)) The multiplex bead array approach to identifying serum biomarkers associated with breast cancer. Breast Cancer Res 11:: R22.
20. Li C, Ford ES, Zhao G, Balluz LS, Giles WH, ((2009)) Estimates of body composition with dual-energy X-ray absorptiometry in adults. Am J Clin Nutr 90:: 1457--1465.
21. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, et al. ((2005)) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288:: E462--468.
22. Wajchenberg BL, Giannella-Neto D, da Silva ME, Santos RF, ((2002)) Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res 34:: 616--621.
23. Vohl MC, Sladek R, Robitaille J, Gurd S, Marceau P, et al. ((2004)) A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Obes Res 12:: 1217--1222.
24. Wang S, Sparks LM, Xie H, Greenway FL, de Jonge L, et al. ((2009)) Subtyping obesity with microarrays: implications for the diagnosis and treatment of obesity. Int J Obes (Lond) 33:: 481--489.
25. Snijder MB, Visser M, Dekker JM, Goodpaster BH, Harris TB, et al. ((2005)) Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia 48:: 301--308.
26. Koster A, Stenholm S, Alley DE, Kim LJ, Simonsick EM, et al. ((2010)) Body fat distribution and inflammation among obese older adults with and without metabolic syndrome. Obesity (Silver Spring) 18:: 2354--2361.
27. Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, et al. ((2004)) Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53:: 2087--2094.
28. Goodpaster BH, Krishnaswami S, Harris TB, Katsiaras A, Kritchevsky SB, et al. ((2005)) Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med 165:: 777--783.
29. Kuk JL, Church TS, Blair SN, Ross R, ((2006)) Does measurement site for visceral and abdominal subcutaneous adipose tissue alter associations with the metabolic syndrome? Diabetes Care 29:: 679--684.
30. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, et al. ((2003)) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46:: 459--469.
31. Koh SJ, Hyun YJ, Choi SY, Chae JS, Kim JY, et al. ((2008)) Influence of age and visceral fat area on plasma adiponectin concentrations in women with normal glucose tolerance. Clin Chim Acta 389:: 45--50.
32. Nakamura Y, Sekikawa A, Kadowaki T, Kadota A, Kadowaki S, et al. ((2009)) Visceral and subcutaneous adiposity and adiponectin in middle-aged Japanese men: the ERA JUMP study. Obesity (Silver Spring) 17:: 1269--1273.
33. Nielsen TL, Hagen C, Wraae K, Brixen K, Petersen PH, et al. ((2007)) Visceral and subcutaneous adipose tissue assessed by magnetic resonance imaging in relation to circulating androgens, sex hormone-binding globulin, and luteinizing hormone in young men. J Clin Endocrinol Metab 92:: 2696--2705.
34. Lee CG, Carr MC, Murdoch SJ, Mitchell E, Woods NF, et al. ((2009)) Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J Clin Endocrinol Metab 94:: 1104--1110.
35. Indulekha K, Anjana RM, Surendar J, Mohan V, ((2011)) Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113). Clin Biochem 44:: 281--287.
36. Carroll JF, Fulda KG, Chiapa AL, Rodriquez M, Phelps DR, et al. ((2009)) Impact of race/ethnicity on the relationship between visceral fat and inflammatory biomarkers. Obesity (Silver Spring) 17:: 1420--1427.
37. Miyazaki Y, DeFronzo RA, ((2009)) Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type. Cardiovasc Diabetol 8:: 44.
38. Tanko LB, Bruun JM, Alexandersen P, Bagger YZ, Richelsen B, et al. ((2004)) Novel associations between bioavailable estradiol and adipokines in elderly women with different phenotypes of obesity: implications for atherogenesis. Circulation 110:: 2246--2252.
39. Fierbinteanu-Braticevici C, Dina I, Petrisor A, Tribus L, Negreanu L, et al. ((2010)) Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis. World J Gastroenterol 16:: 4784--4791.
40. Loomba R, Rao F, Zhang L, Khandrika S, Ziegler MG, et al. (2010) Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins. Gastroenterology 139: 836-845, 845 e831.
41. Nobili V, Manco M, Ciampalini P, Diciommo V, Devito R, et al. ((2006)) Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease. Eur J Endocrinol 155:: 735--743.
42. Turer AT, Browning JD, Ayers CR, Das SR, Khera A, et al. (2012) Adiponectin as an Independent Predictor of the Presence and Degree of Hepatic Steatosis in the Dallas Heart Study. J Clin Endocrinol Metab.
43. Ishii M, Yoshioka Y, Ishida W, Kaneko Y, Fujiwara F, et al. ((2005)) Liver fat content measured by magnetic resonance spectroscopy at 3.0 tesla independently correlates with plasminogen activator inhibitor-1 and body mass index in type 2 diabetic subjects. Tohoku J Exp Med 206:: 23--30.
44. Ix JH, Wassel CL, Chertow GM, Koster A, Johnson KC, et al. ((2009)) Fetuin-A and change in body composition in older persons. J Clin Endocrinol Metab 94:: 4492--4498.
45. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, et al. ((2007)) High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. Diabetes Care 30:: 1173--1178.
46. Tonjes A, Bluher M, Stumvoll M, ((2010)) Retinol-binding protein 4 and new adipocytokines in nonalcoholic fatty liver disease. Curr Pharm Des 16:: 1921--1928.
47. Kotronen A, Seppanen-Laakso T, Westerbacka J, Kiviluoto T, Arola J, et al. ((2010)) Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serum. Obesity (Silver Spring) 18:: 937--944.
48. Bea JW, Wright NC, Thompson P, Hu C, Guerra S, et al. ((2011)) Performance evaluation of a multiplex assay for future use in biomarker discovery efforts to predict body composition. Clin Chem Lab Med 49:: 817--824.
49. Sun Q, van Dam RM, Spiegelman D, Heymsfield SB, Willett WC, et al. ((2010)) Comparison of dual-energy x-ray absorptiometric and anthropometric measures of adiposity in relation to adiposity-related biologic factors. Am J Epidemiol 172:: 1442--1454.
50. Kumagai S, Kishimoto H, Masatakasuwa, Zou B, ((2005)) Harukasasaki ((2005)) The leptin to adiponectin ratio is a good biomarker for the prevalence of metabolic syndrome, dependent on visceral fat accumulation and endurance fitness in obese patients with diabetes mellitus. Metab Syndr Relat Disord 3:: 85--94.
51. Montague CT, O'Rahilly S, ((2000)) The perils of portliness: causes and consequences of visceral adiposity. Diabetes 49:: 883--888.
52. Kabir M, Catalano KJ, Ananthnarayan S, Kim SP, Van Citters GW, et al. ((2005)) Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab 288:: E454--461.
53. Bergman RN, Kim SP, Catalano KJ, Hsu IR, Chiu JD, et al. ((2006)) Why visceral fat is bad: mechanisms of the metabolic syndrome. Obesity (Silver Spring) 14 (Suppl 1):: 16S--19S.
54. Rose DP, Haffner SM, Baillargeon J, ((2007)) Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women. Endocr Rev 28:: 763--777.
55. Beasley LE, Koster A, Newman AB, Javaid MK, Ferrucci L, et al. ((2009)) Inflammation and race and gender differences in computerized tomography-measured adipose depots. Obesity (Silver Spring) 17:: 1062--1069.
56. Young KA, Engelman CD, Langefeld CD, Hairston KG, Haffner SM, et al. ((2009)) Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. J Clin Endocrinol Metab 94:: 3306--3313.
57. Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, et al. ((2007)) Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 17:: 517--524.
58. Harrell FE (2010) Regression modeling strategies. New York: Springer.